HCA Healthcare's Q3 Earnings Soar on Strong Revenue Growth

TL;DR

**HCA is crushing it, with net income up nearly 30% this quarter, making it a strong buy despite rising costs.**

AI Summary

HCA Healthcare, Inc. reported robust financial performance for the quarter and nine months ended September 30, 2025. Revenues increased by 9.57% to $19.161 billion for the quarter, up from $17.487 billion in the prior year, and by 7.21% to $56.087 billion for the nine months, compared to $52.318 billion in 2024. Net income attributable to HCA Healthcare, Inc. surged by 29.37% to $1.643 billion for the quarter, from $1.270 billion, and by 13.51% to $4.906 billion for the nine months, up from $4.322 billion. Diluted earnings per share rose significantly to $6.96 for the quarter (from $4.88) and $20.23 for the nine months (from $16.37). Key business changes include the acquisition of two hospital facilities in New Hampshire and Florida for $190 million and nonhospital health care entities for $171 million during the nine months ended September 30, 2025. Risks include increased operating expenses, with salaries and benefits rising to $8.364 billion for the quarter and $24.499 billion for the nine months, and interest expense increasing to $561 million for the quarter and $1.676 billion for the nine months. The strategic outlook appears focused on continued expansion through acquisitions and managing uncompensated care costs, which totaled an estimated $3.359 billion for the nine months ended September 30, 2025.

Why It Matters

HCA's strong financial performance, particularly the significant increase in net income and diluted EPS, signals robust demand for healthcare services and effective cost management, which is positive for investors. The company's strategic acquisitions of hospital and non-hospital healthcare entities demonstrate a commitment to expanding its market presence and service offerings, potentially intensifying competition in regional healthcare markets. For employees, sustained profitability could lead to job security and potential benefits, while customers may see expanded access to HCA's network. The broader market will watch HCA's ability to manage rising operating expenses, especially salaries and benefits, as a bellwether for the healthcare sector's inflationary pressures.

Risk Assessment

Risk Level: medium — The risk level is medium due to significant increases in operating expenses, particularly salaries and benefits, which rose to $8.364 billion for the quarter ended September 30, 2025, from $7.861 billion in the prior year. Additionally, interest expense increased to $561 million for the quarter, up from $515 million, indicating higher borrowing costs or increased debt levels. The company also reported a substantial increase in short-term borrowings and long-term debt due within one year, rising to $6.110 billion from $4.698 billion at December 31, 2024.

Analyst Insight

Investors should consider HCA Healthcare's strong earnings growth and strategic acquisitions as positive indicators for long-term value. However, closely monitor the rising operating expenses and increasing debt, as these could impact future profitability. Evaluate HCA's ability to integrate new acquisitions efficiently and manage its debt load effectively.

Financial Highlights

debt To Equity

N/A

revenue

$19.161B

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

$1.643B

eps

$6.96

gross Margin

N/A

cash Position

N/A

revenue Growth

+9.57%

Revenue Breakdown

Key Numbers

• $19.161B — Quarterly Revenues (Increased 9.57% from $17.487B in Q3 2024)
• $56.087B — Nine-Month Revenues (Increased 7.21% from $52.318B in 2024)
• $1.643B — Quarterly Net Income Attributable to HCA (Increased 29.37% from $1.270B in Q3 2024)
• $4.906B — Nine-Month Net Income Attributable to HCA (Increased 13.51% from $4.322B in 2024)
• $6.96 — Quarterly Diluted EPS (Increased from $4.88 in Q3 2024)
• $20.23 — Nine-Month Diluted EPS (Increased from $16.37 in 2024)
• $8.364B — Quarterly Salaries and Benefits (Increased from $7.861B in Q3 2024)
• $561M — Quarterly Interest Expense (Increased from $515M in Q3 2024)
• $6.110B — Short-term borrowings and long-term debt due within one year (Increased from $4.698B at December 31, 2024)
• $7.509B — Repurchase of common stock (Increased from $4.342B for the nine months ended September 30, 2024)

Key Players & Entities

• HCA Healthcare, Inc. (company) — registrant
• $19.161 billion (dollar_amount) — Q3 2025 revenues
• $17.487 billion (dollar_amount) — Q3 2024 revenues
• $56.087 billion (dollar_amount) — Nine months 2025 revenues
• $52.318 billion (dollar_amount) — Nine months 2024 revenues
• $1.643 billion (dollar_amount) — Q3 2025 net income attributable to HCA Healthcare, Inc.
• $1.270 billion (dollar_amount) — Q3 2024 net income attributable to HCA Healthcare, Inc.
• $4.906 billion (dollar_amount) — Nine months 2025 net income attributable to HCA Healthcare, Inc.
• $4.322 billion (dollar_amount) — Nine months 2024 net income attributable to HCA Healthcare, Inc.
• $6.96 (dollar_amount) — Q3 2025 diluted earnings per share

FAQ

Risk Factors

• Increased Operating Expenses [high — operational]: Salaries and benefits rose to $8.364 billion for the quarter and $24.499 billion for the nine months. This increase puts pressure on margins if not offset by revenue growth or efficiency gains.
• Rising Interest Expense [medium — financial]: Interest expense increased to $561 million for the quarter and $1.676 billion for the nine months. This is a direct consequence of higher debt levels, impacting net income.
• Uncompensated Care Costs [high — regulatory]: The company incurred an estimated $3.359 billion in uncompensated care costs for the nine months ended September 30, 2025. This significant cost burden impacts profitability and requires careful management.
• Competition and Payer Mix [medium — market]: The healthcare landscape is competitive, and changes in payer mix (e.g., shift towards government payers with lower reimbursement rates) can negatively affect revenue and profitability.
• Debt Management [medium — financial]: Short-term borrowings and long-term debt due within one year increased to $6.110 billion. Managing this debt load and associated interest payments is crucial for financial stability.

Industry Context

The U.S. healthcare industry continues to face pressures from rising labor costs, evolving reimbursement models, and increasing demand for services. Consolidation through mergers and acquisitions remains a key strategy for providers like HCA to achieve scale and efficiency. The ongoing focus on value-based care and managing uncompensated care are critical industry-wide challenges.

Regulatory Implications

HCA operates within a highly regulated environment. Changes in healthcare policy, reimbursement rates from government programs (Medicare/Medicaid), and compliance with healthcare laws (e.g., Stark Law, Anti-Kickback Statute) pose ongoing risks. The significant uncompensated care costs also highlight the social and financial implications of access to care.

What Investors Should Do

1. Monitor operating expense trends, particularly salaries and benefits, to assess margin sustainability.
2. Evaluate the impact of acquisitions on overall financial performance and integration success.
3. Analyze the trend of uncompensated care costs and management's strategies to mitigate this impact.
4. Assess the company's debt levels and interest expense in light of rising interest rates and acquisition financing.

Key Dates

• 2025-09-30: Quarter and Nine Months Ended — Reporting period for the financial results, showing significant revenue and net income growth.
• 2025-09-30: Acquisition of Hospitals and Health Entities — Strategic expansion through acquisitions totaling $361 million ($190M for hospitals, $171M for nonhospital entities), indicating a growth-oriented strategy.
• 2025-09-30: Nine Months Uncompensated Care Costs — Estimated $3.359 billion in uncompensated care highlights a significant operational challenge and cost factor.

Glossary

Uncompensated Care

Healthcare services provided to patients who are unable to pay for their care, including charity care and bad debt. (A significant cost for HCA, impacting profitability and requiring strategic management.)

Diluted Earnings Per Share (EPS)

A company's net profit divided by the number of common shares outstanding, adjusted for all dilutive potential common shares. (Indicates the profitability on a per-share basis, a key metric for investors. HCA's EPS increased significantly to $6.96 for the quarter.)

Payer Mix

The proportion of revenue generated from different types of insurance providers, such as commercial insurance, Medicare, and Medicaid. (Changes in payer mix can significantly impact revenue and profitability due to varying reimbursement rates.)

Year-Over-Year Comparison

HCA Healthcare demonstrated strong year-over-year performance, with quarterly revenues growing 9.57% to $19.161 billion and net income surging 29.37% to $1.643 billion. This growth is accompanied by a significant increase in operating expenses, notably salaries and benefits, which rose to $8.364 billion for the quarter. Debt levels have also increased, with short-term borrowings and long-term debt due within one year rising to $6.110 billion, contributing to higher interest expenses. The company continues to pursue strategic acquisitions, adding to its asset base and potential future revenue streams.

Filing Documents

• hca-20250930.htm (10-Q) — 3264KB
• hca-ex10_1.htm (EX-10.1) — 1630KB
• hca-ex10_2.htm (EX-10.2) — 131KB
• hca-ex22.htm (EX-22) — 5KB
• hca-ex31_1.htm (EX-31.1) — 15KB
• hca-ex31_2.htm (EX-31.2) — 17KB
• hca-ex32.htm (EX-32) — 17KB
• 0001193125-25-258667.txt ( ) — 12797KB
• hca-20250930.xsd (EX-101.SCH) — 916KB
• hca-20250930_htm.xml (XML) — 2292KB

Financial Statements (Unaudited)

Financial Statements (Unaudited): Condensed Consolidated Income Statements — for the quarters and nine months ended September 30, 2025 and 2024 3 Condensed Consolidated Comprehensive Income Statements — for the quarters and nine months ended September 30, 2025 and 2024 4 Condensed Consolidated Balance Sheets — September 30, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Stockholders' Equity (Deficit) — for the quarters and nine months ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows — for the nine months ended September 30, 2025 and 2024 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 31 Item 4.

Controls and Procedures

Controls and Procedures 31 Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 31 Item 1A.

Risk Factors

Risk Factors 31 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 Item 5. Other Information 32 Item 6. Exhibits 32

Signatures

Signatures 33 2 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED INCOME STATEMENTS FOR THE QUARTERS AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 Unaudited (Dollars in millions, except per share amounts) Quarter Nine Months 2025 2024 2025 2024 Revenues $ 19,161 $ 17,487 $ 56,087 $ 52,318 Salaries and benefits 8,364 7,861 24,499 23,253 Supplies 2,782 2,657 8,390 7,962 Other operating expenses 4,161 3,717 11,799 10,946 Equity in earnings of affiliates ( 16 ) ( 15 ) ( 53 ) ( 13 ) Depreciation and amortization 889 842 2,612 2,456 Interest expense 561 515 1,676 1,533 Losses (gains) on sales of facilities 2 4 4 ( 209 ) 16,743 15,581 48,927 45,928 Income before income taxes 2,418 1,906 7,160 6,390 Provision for income taxes 515 424 1,541 1,419 Net income 1,903 1,482 5,619 4,971 Net income attributable to noncontrolling interests 260 212 713 649 Net income attributable to HCA Healthcare, Inc. $ 1,643 $ 1,270 $ 4,906 $ 4,322 Per share data: Basic earnings $ 7.05 $ 4.94 $ 20.47 $ 16.57 Diluted earnings $ 6.96 $ 4.88 $ 20.23 $ 16.37 Shares used in earnings per share calculations (in millions): Basic 232.891 256.763 239.615 260.770 Diluted 236.181 259.917 242.459 263.987 The accompanying notes are an integral part of the condensed consolidated financial statements. 3 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS FOR THE QUARTERS AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 Unaudited (Dollars in millions) Quarter Nine Months 2025 2024 2025 2024 Net income $ 1,903 $ 1,482 $ 5,619 $ 4,971 Other comprehensive income (loss) before taxes: Foreign currency translation ( 14 ) 55 71 48 Unrealized gains on available-for-sale securities 3 13 12

View Full Filing

View this 10-Q filing on SEC EDGAR